(2014). An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK. Value Health. http://doi.org/10.1016/j.jval.2014.08.782.
(2015). Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12458.
(2016). Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database. Curr Med Res Opin. http://doi.org/10.1185/03007995.2016.1157462.
(2017). Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database study. Int J Clin Pract. http://doi.org/10.1111/ijcp.12958.